Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 73.50
+0.10 (0.14%)
Sep 8, 2026, 1:48 PM CST
TPEX:7427 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -111.67 | -97.47 | -104.92 | -61 | -67.13 | -35.86 |
Depreciation & Amortization | 6.75 | 7.62 | 6.9 | 4.28 | 1.76 | 1.44 |
Other Amortization | 0.08 | 0.07 | 0.04 | 0.07 | 0.06 | 0.06 |
Loss (Gain) From Sale of Assets | 1.21 | - | - | -0.12 | - | - |
Stock-Based Compensation | 10.69 | 11.16 | 14.97 | 11.29 | 4.91 | 3.66 |
Other Operating Activities | 0.08 | 0.1 | 0.13 | 0.09 | -0.01 | -0.03 |
Change in Accounts Receivable | -3.13 | 0.65 | -0.62 | -0.09 | - | -0.04 |
Change in Inventory | -6.37 | -4.28 | 3.15 | -6.16 | - | - |
Change in Accounts Payable | 9.54 | -2.95 | 6.61 | 1.05 | - | - |
Change in Other Net Operating Assets | 5.03 | -2.44 | -3.09 | -4.4 | -16.76 | -3.15 |
Operating Cash Flow | -87.79 | -87.56 | -76.85 | -54.99 | -77.17 | -33.92 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.28 | -0.28 | -2.11 | -2.93 | -0.05 | -0.04 |
Sale of Property, Plant & Equipment | - | - | - | 0.12 | - | - |
Sale (Purchase) of Intangibles | -3.83 | -3.21 | -1.36 | -16.29 | -1.18 | -27.97 |
Investment in Securities | -309.7 | 10 | -130.7 | -160.5 | -74.19 | -62.32 |
Other Investing Activities | 2.56 | 2.86 | 0.68 | -3.18 | -2.45 | - |
Investing Cash Flow | -311.25 | 9.37 | -133.49 | -182.78 | -77.85 | -90.32 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -3 | -3 | -1.25 | - | - |
Lease Payments | -3.01 | -3 | -3 | -1.25 | - | - |
Net Debt Issued (Repaid) | -3.01 | -3 | -3 | -1.25 | - | - |
Issuance of Common Stock | 305.74 | 0.94 | 188.84 | 307.49 | 203.31 | 120 |
Repurchase of Common Stock | -14.99 | -44.97 | - | - | - | - |
Financing Cash Flow | 287.74 | -47.03 | 185.84 | 306.24 | 203.31 | 120 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -111.3 | -125.22 | -24.49 | 68.47 | 48.29 | -4.24 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -88.07 | -87.84 | -78.96 | -57.92 | -77.21 | -33.96 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -1418.65% | -7289.46% | -4685.82% | -1194.21% | -14298.70% | -5389.68% |
Free Cash Flow Per Share | -1.99 | -2.04 | -1.92 | -1.60 | -3.20 | -1.61 |
Levered Free Cash Flow | -50.58 | -52.5 | -53.21 | -48.79 | -50.61 | -29.53 |
Unlevered Free Cash Flow | -50.53 | -52.44 | -53.14 | -48.73 | -50.61 | -29.53 |
Free Cash Flow After Leases | -91.08 | -90.84 | -81.95 | -59.17 | -77.21 | -33.96 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 5.07 | -9.03 | 6.04 | -9.6 | -16.76 | -3.19 |